Can a meditation app soothe teen eczema?

NCT ID NCT07746427

Recruiting now Symptom relief Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This trial tests whether regular use of a digital mindfulness meditation app can help adolescents aged 12-17 with moderate to severe atopic dermatitis (eczema) improve disease control and quality of life. Participants will use the app for 10-15 minutes, 3-4 times a week, while a comparison group reads an informational handout on mindfulness. The study measures changes in eczema control and quality of life using validated surveys, and also asks teens about the app's ease of use and accessibility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A digital mindfulness meditation app used regularly, compared with reading an informational handout on mindfulness meditation.
What this could lead to: If it works, this could offer an accessible, drug-free way to help teens with eczema feel better and gain more control over their condition.
What could go wrong: This is a small, early-stage trial, so results may not apply to everyone. The app may not improve eczema control or quality of life, and benefits could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS ECZEMA

Contacts and locations

Locations

Columbia University Irving Medical Center
RECRUITING

New York, New York, 10036, United States
Weill Cornell Medicine
NOT_YET_RECRUITING

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.